World Asthma Day: Why Access to Anti‑Inflammatory Inhalers Still Matters

World Asthma Day is a global opportunity to reflect on how far asthma care has come and how far we still have to go.

 

This year’s theme, “Access to anti-inflammatory inhalers for everyone with asthma – still an urgent need,” highlights an issue we see every day in pediatric healthcare: asthma outcomes depend on a patient’s ability to access and use the medications that control their disease.

 

Asthma is a chronic inflammatory condition of the airways that affects millions of children and adults across the United States. It remains one of the leading causes of emergency department visits, hospital admissions, missed school days, and missed workdays. While effective treatments exist, asthma continues to place a heavy burden on families, communities, and healthcare systems.

 

What’s often overlooked is that relief alone is not enough.

 

Short‑acting rescue inhalers treat symptoms in the moment, but anti‑inflammatory controller medications address the underlying airway inflammation that drives asthma attacks. Without consistent access to these medications, asthma remains uncontrolled, and preventable exacerbations continue to occur.

 

For many families, especially in rural states like West Virginia, obtaining consistent access to anti‑inflammatory inhalers is not guaranteed. Factors such as medication costs, insurance coverage, pharmacy availability, transportation challenges, and educational gaps can stand between a child and the medication they need to stay healthy.

 

When access is limited, asthma symptoms worsen, emergency visits increase, school and family life are disrupted, and the risk of severe or even fatal asthma attacks rises. These are not failures of treatment; they are failures of access.

 

At WVU Medicine Golisano Children’s, we care for children with asthma across a wide geographic region, many of whom face barriers to specialty care and ongoing follow-up. Our asthma program is dedicated to more than just treating symptoms; we focus on prevention, education, and long-term disease control.

 

Ensuring families understand why anti‑inflammatory inhalers matter and how to use them correctly is just as important as prescribing them. Equally important is advocating for systems that make these medications accessible, affordable, and sustainable for every child who needs them.

 

Through patient‑centered care, caregiver education, and community outreach, we work to reduce disparities and support equitable asthma care across the state.

 

World Asthma Day and National Asthma and Allergy Awareness Month remind us that improving asthma outcomes requires more than clinical expertise; it requires awareness, advocacy, and collaboration. From bedside care to clinic visits, from education to policy, every role within our children’s hospital contributes to helping children breathe easier.

 

Access to anti‑inflammatory inhalers saves lives. Until every child with asthma can reliably obtain and use these medications, the work remains unfinished.

 

At WVU Medicine Golisano Children’s, we stand with every child and family navigating asthma. We will continue to educate, empower, and advocate because every child deserves the chance to breathe freely.

 

For more information about WVU Medicine Golisano Children’s Asthma services, call (304) 598-4690.

 

Written by Jamie Rice, BSRT, RRT-NPS, RRT-ACCS, AE-C, Asthma Program Coordinator